These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28462876)

  • 1. [AA amyloidosis].
    Stojanovic KS; Georgin-Lavialle S; Grateau G
    Nephrol Ther; 2017 Jun; 13(4):258-264. PubMed ID: 28462876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Amyloidosis AA].
    Stankovic K; Grateau G
    Nephrol Ther; 2008 Jul; 4(4):281-7. PubMed ID: 18514052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colchicine use in isolated renal AA amyloidosis.
    Meneses CF; Egües CA; Uriarte M; Belzunegui J; Rezola M
    Reumatol Clin; 2015; 11(4):242-3. PubMed ID: 25453598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. French practical guidelines for the diagnosis and management of AA amyloidosis.
    Georgin-Lavialle S; Savey L; Buob D; Bastard JP; Fellahi S; Karras A; Boffa JJ; Grateau G; ; Audard V; Bridoux F; Damade R; Deshayes S; Giurgea I; Granel B; Hachulla E; Hot A; Jaccard A; Knebelmann B; Marciano S; Pelcot F; Sarrabay G; Boursier G; Sellam J; Terre A; Bourguiba R
    Rev Med Interne; 2023 Feb; 44(2):62-71. PubMed ID: 36759076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term prognosis of AL and AA renal amyloidosis: a Japanese single-center experience.
    Ozawa M; Komatsuda A; Ohtani H; Nara M; Sato R; Togashi M; Takahashi N; Wakui H
    Clin Exp Nephrol; 2017 Apr; 21(2):212-227. PubMed ID: 27116248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renal amyloidosis].
    Cuchard P; Cuchard R; Rotman S; Burnier M; Gauthier T
    Rev Med Suisse; 2012 Feb; 8(330):446-51. PubMed ID: 22452129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secondary amyloidosis (AA) and renal disease].
    Torregrosa E; Hernández-Jaras J; Calvo C; Ríus A; García-Pérez H; Maduell F; Vera JM
    Nefrologia; 2003; 23(4):321-6. PubMed ID: 14558331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes and survival in AA amyloidosis patients.
    Ayar Y; Ersoy A; Oksuz MF; Ocakoglu G; Vuruskan BA; Yildiz A; Isiktas E; Oruc A; Celikci S; Arslan I; Sahin AB; Güllülü M
    Rev Bras Reumatol Engl Ed; 2017; 57(6):535-544. PubMed ID: 29173691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal amyloidosis].
    Kościelska M; Shebani Z; Matuszkiewicz-Rowińska J
    Przegl Lek; 2013; 70(4):205-10. PubMed ID: 23991559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic blockade of interleukin-6 by tocilizumab in the management of AA amyloidosis and chronic inflammatory disorders: a case series and review of the literature.
    Lane T; Gillmore JD; Wechalekar AD; Hawkins PN; Lachmann HJ
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S46-53. PubMed ID: 26120866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First Nationwide Survey of 199 Patients with Amyloid A Amyloidosis in Japan.
    Okuda Y; Yamada T; Ueda M; Ando Y
    Intern Med; 2018 Dec; 57(23):3351-3355. PubMed ID: 30101921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AA amyloidosis: basic knowledge, unmet needs and future treatments.
    Obici L; Merlini G
    Swiss Med Wkly; 2012; 142():w13580. PubMed ID: 22653707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary, AA, Amyloidosis.
    Papa R; Lachmann HJ
    Rheum Dis Clin North Am; 2018 Nov; 44(4):585-603. PubMed ID: 30274625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Causes and treatment of systemic amyloidosis].
    Blank N; Hegenbart U; Schönland S
    Z Rheumatol; 2016 Mar; 75(2):141-50. PubMed ID: 26768274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic inflammation and AA amyloidosis].
    Blank N; Schönland SO
    Dtsch Med Wochenschr; 2013 Sep; 138(37):1835-8. PubMed ID: 24006165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of infliximab induction therapy on secondary systemic amyloidosis associated with Crohn's disease: case report and review of the literature.
    Pukitis A; Zake T; Groma V; Ostrovskis E; Skuja S; Pokrotnieks J
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):333-6. PubMed ID: 24078992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Autoinflammatory syndromes and AA amyloidosis].
    Blank N; Schönland SO
    Z Rheumatol; 2020 Sep; 79(7):649-659. PubMed ID: 32253511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Systemic AA amyloidosis induced by benign neoplasms].
    Bestard Matamoros O; Poveda Monje R; Ibernon Vilaró M; Carrera Plans M; Grinyó Boira JM
    Nefrologia; 2008; 28(1):93-8. PubMed ID: 18336138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal involvement in systemic amyloidosis: an Italian collaborative study on survival and renal outcome.
    Bergesio F; Ciciani AM; Manganaro M; Palladini G; Santostefano M; Brugnano R; Di Palma AM; Gallo M; Rosati A; Tosi PL; Salvadori M;
    Nephrol Dial Transplant; 2008 Mar; 23(3):941-51. PubMed ID: 17951308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal amyloidosis in childhood. An overview of the topic with 25 years experience.
    Tinaztepe K
    Turk J Pediatr; 1995; 37(4):357-73. PubMed ID: 8560604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.